CLINICAL_TRIALS
trial_result
· 2015-05-05
Clinical Trial Update: Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease [Phase 3]
Summary
Phase 3 study of nitazoxanide for the treatment of Clostridioides difficile infection has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Romark Laboratories L.C. | Conditions: Clostridium Infections | Phase 3 | Status: TERMINATED